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Resistance in Anopheles gambiae to members of all 4 major classes
(pyrethroids, carbamates, organochlorines, and organophosphates)
of public health insecticides limits effective control of malaria trans-
mission in Africa. Increase in expression of detoxifying enzymes has
been associated with insecticide resistance, but their direct func-
tional validation in An. gambiae is still lacking. Here, we perform
transgenic analysis using the GAL4/UAS system to examine insecti-
cide resistance phenotypes conferred by increased expression of the 3
genes—Cyp6m2, Cyp6p3, and Gste2—most often found up-regulated
in resistant An. gambiae. We report evidence in An. gambiae that
organophosphate and organochlorine resistance is conferred by over-
expression of GSTE2 in a broad tissue profile. Pyrethroid and carba-
mate resistance is bestowed by similar Cyp6p3 overexpression, and
Cyp6m2 confers only pyrethroid resistance when overexpressed in
the same tissues. Conversely, such Cyp6m2 overexpression increases
susceptibility to the organophosphate malathion, presumably due to
conversion to the more toxic metabolite, malaoxon. No resistant phe-
notypes are conferred when either Cyp6 gene overexpression is re-
stricted to the midgut or oenocytes, indicating that neither tissue is
involved in insecticide resistance mediated by the candidate P450s
examined. Validation of genes conferring resistance provides markers
to guide control strategies, and the observed negative cross-resistance
due to Cyp6m2 gives credence to proposed dual-insecticide strategies
to overcome pyrethroid resistance. These transgenic An. gambiae-
resistant lines are being used to test the “resistance-breaking” efficacy
of active compounds early in their development.
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GAL4/UAS
The number of worldwide malaria cases reduced steadily from2000 until 2015, mainly due to the widespread rollout of
insecticide-treated bed nets in endemic areas (1), which offer
protection against bites from Plasmodium-infected Anopheles
mosquitoes. Since then, the drop in malaria cases has stalled (2),
which has been attributed partially to the increasing levels of in-
secticide resistance found in Anopheles vectors (3). Resistance in
dominant African Anopheles vectors has been recorded to all
major insecticide classes currently used in public health (pyrethroids,
organochlorines, carbamates, and organophosphates [OPs]) (4).
Therefore, understanding the mechanisms by which mosquitoes
evolve resistance is critical for the design of mitigation strategies
and in the evaluation of new classes of insecticides.
Research into the molecular mechanisms that give rise to re-
sistance in mosquitoes has identified target site modifications and
increased metabolic detoxification (detox) as the 2 main evolu-
tionary adaptions (5) that often coexist in Anopheles gambiae.
Families of detoxification enzymes, including cytochromes P450
(CYPs) and glutathione-S-transferases (GSTs), can provide phase
I metabolism of insecticides and phase II conjugation reactions
that alter the toxicity of compounds and increase polarity, en-
hancing excretion (6, 7).
To identify and characterize the role of the causative resis-
tance genes from these detoxification families, a sequential process
of transcriptomic, proteomic, and in vivo functional analysis is often
applied (8). Candidate genes with up-regulated transcription or
strong signatures of selection in resistant mosquitoes are typically
expressed in bacteria to provide evidence of insecticide depletion
and/or metabolism in vitro (9–19). Further studies have used the
Drosophila melanogaster transgenic model to determine whether
expression of single Anopheles genes confers increased tolerance to
insecticides (13–18, 20).
This workflow has implicated a role in resistance of 2 CYP
genes, Cyp6m2 and Cyp6p3, and a GST gene, Gste2, that are
consistently up-regulated in resistant field populations found across
Africa (21). However, there are often discrepancies in results from
recombinant protein activity and transgenic D. melanogaster anal-
yses. For example, while expression studies of Cyp6m2 and Cyp6p3
in Escherichia coli (10, 11) and D. melanogaster (15) suggest that
both gene products can detoxify pyrethroids, the 2 systems produce
conflicting results in respect to carbamate (15) and organochlorine
insecticide detoxification (12, 15, 19). Moreover, the involvement
of An. gambiae and Anopheles funestus Gste2 (AfGste2) orthologs in
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resistance to pyrethroid insecticides has produced contradictory
results when explored in D. melanogaster (16, 20).
Clearly, functional validation of Anopheles genes directly in
the mosquito would provide the benchmark approach to address
these questions; however, to date, transgenic tools to perform
such analysis have been limited. To this end, we have developed
the GAL4/UAS expression system in An. gambiae (22–24), which
allows genes to be overexpressed in a susceptible mosquito
background and for resultant resistance phenotypes to be ex-
amined using the standard insecticide assays that have been
developed for comparative analysis in mosquitoes by the World
Health Organization (WHO) (25).
In vivo functional analysis in Anopheles can also help discover
the mosquito tissues that are specifically involved in insecticide
metabolism. Our previous research indicated high P450 activity
in the midgut and oenocytes, since the essential P450 coenzyme,
cytochrome P450 reductase (CPR), is highly expressed in these
tissues, and RNA interference (RNAi) knockdown of Cpr in-
creased mosquito sensitivity to a pyrethroid insecticide (26).
Moreover, Cyp6m2 has been reported as enriched in the An.
gambiae midgut (11), and Cyp6p3 was found up-regulated in
midguts from pyrethroid-resistant populations (27).
Here, we have used the GAL4/UAS system to overexpress
Cyp6m2 or Cyp6p3 genes in multiple tissues or specifically in the
midgut or oenocytes of a susceptible An. gambiae strain and
assayed the modified mosquitoes against representatives of each
insecticide class available for public health use. In doing so, we
determined the resistance profile generated for each gene and
compared these results with those obtained in D. melanogaster
and in vitro. We then analyzed the other major candidate, Gste2,
to examine its role in conferring dichloro-diphenyl-trichloro-
ethane (DDT) resistance and also, extended its testing to other
classes of insecticides in which its role has yet to be tested in vivo.
In this work, we report the use of the GAL4/UAS system in An.
gambiae as a benchmark to determine whether single candidate
genes and/or expression in individual tissues are able to confer
WHO-defined levels of resistance to the 4 public health classes of
insecticides, including OPs. Crucially we find that, when assayed in
An. gambiae, overexpression of Cyp6m2, Cyp6p3, or Gste2 produces
cross-resistance phenotypes that encompass members of all 4 classes
of insecticides currently used for malaria control.
Results
Mosquito Lines Generated for UAS-Regulated Expression of Cyp6m2
and Cyp6P3. YFP-marked UAS-Cyp6m2 and -Cyp6p3 lines were
created by site-directed recombination-mediated cassette ex-
change (RMCE) into the docking (CFP:2xattP) line A11 (24) to
produce mosquitoes carrying transgene insertions in the same
genomic site. By normalizing potential genomic position effect,
this allows more reliable comparison of the consequences of
Cyp6m2 and Cyp6p3 overexpression on resistance.
A summary of the screening and crossing strategy used to
create the UAS responder lines is illustrated in Table 1. RMCE
results in canonical cassette exchange in 2 potential orientations;
however, integration of the whole donor transgene can also oc-
cur in either attP site. Fluorescent marker screening of F1
progenies from F0 pooled mosquitoes revealed that cassette ex-
change and integration events occurred in all experiments as
shown by the recovery of individuals carrying single (YFP: ex-
change) or double (YFP/CFP: integration) markers (Table 1).
Molecular analysis revealed one exchange orientation (A) in
transgenic UAS-m2 individuals and both orientations for UAS-p3
transformation as indicated by diagnostic PCR (SI Appendix, Fig.
S1). Overall, we found at least 2 events for UAS-m2 trans-
formation, having equal efficiencies of 2% for cassette exchange
and integration (1/49 F0 founders); for the UAS-p3 transformation,
at least 9 transformation events (6 cassette exchanges, 3 in each
orientation, and 3 transgene integrations) were detected, with a
minimum cassette exchange efficiency of 5% (6/124 F0) and in-
tegration efficiency of 2% (3/124 F0). For comparative functional
analysis, representative Cyp6 lines in orientation A were main-
tained and crossed with alternative GAL4 driver lines.
CYP6M2 or CYP6P3 Overexpression in Multiple Tissues Causes Distinct
Profiles of Resistance to Pyrethroids and Bendiocarb. We previously
described the production of a GAL4 driver line, Ubi-A10, directing
widespread tissue expression (23). To quantify the overexpression
achieved with this driver, we performed qRT-PCR in the progeny of
Table 1. Summary of the screening and crossing strategy adopted to create and establish the UAS responder lines by RMCE
Docking line (no. of embryos) and F0 pools
(no. and sex) F0 isofemale
F1 transgenics
Orientation of cassette exchange*YFP+ YFP+/CFP+
A11_UAS-Cyp6m2 (347)
M2-1 (24 \) G 0 2 N/A
J 2_ 0 2 F1 _-A
M2-2 (25 _) N/A 0 0 N/A
A11_UAS-Cyp6p3 (460)
P3-1 (28 \) N/A 7\, 4_ 1 5 F1 \-A ×2, B ×3
P3-2 (27 \) N/A 2\, 8_ 2 2 F1 \-A, B
P3-3 (13 \) N/A 0 0 N/A
P3-4 (56 _) N/A 10\, 13_ 4 3 F1 \-A, B ×2
Ubi-A10_UAS-Gste2 (208)
E2-1 (10 _) N/A 0 0 N/A
E2-2 (12 \) N/A 0 0 N/A
E2-3 (19 _) N/A 2_ 36\, 44 _ 2 F1 _-A
E2-4 (24 \) A 3\, 3_ (7)† F2 progeny of 1 F1 _-B
E 4\, 3 _ 2\, 2_ 1 F1 \-A F2 progeny of 1 F1 _-A
Numbers in brackets after the docking line names in column 1 refer to number of eggs injected. M2, P3, and E2 refer to pools of single sex F0 adults
(number of mosquitoes given in brackets) collected post injection that gave rise to F1 progeny. G, J, A, and E refer to F0 females laying eggs individually that
gave rise to isofemale lines. N/A, not applicable. YFP+ and YFP+/CFP+ indicate the number and sex of F1 progeny showing YFP or YFP and CFP fluorescence,
respectively.
*As cassette exchange may occur in 2 different orientations with respect to the chromosome, designated A or B, orientation check was performed on F1 YFP+
individuals or on the F2 progeny derived from single YFP+ individuals.
†Did not survive to adulthood.
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Ubi-A10 driver and UAS-Cyp6 crosses. This revealed significant
2,447× (P = 0.005) and 513× (P < 0.001) increases of Cyp6m2 and
Cyp6p3 transcript abundance, respectively, in adult females com-
pared with native expression in respective controls (Fig. 1A).
Western analysis also readily detected CYP6M2 in the adult female
progeny of the Ubi-A10/UAS-m2 crosses but was beyond the level
of detection in sibling controls (Ubi-A10/+ and +/UAS-m2) (Fig.
1B). No suitable antiserum was available for analysis of CYP6P3.
WHO discriminating dose assays were then performed to assess
the susceptibility of mosquitoes overexpressing Cyp6m2 or Cyp6p3
compared with their Ubi-A10/+ siblings. WHO tube bioassays are
used to screen for the emergence of resistance in field populations
and involve exposing mosquitoes to fixed concentration of insec-
ticides (twice the lethal concentration that kills 99% of a suscep-
tible population) for 60 min followed by a 24-h recovery period
before recording mortality (25). The parental strains used here are
susceptible (>90% mortality) to all of the insecticides tested;
therefore, a decrease in mortality in test assays can be directly
attributable to the overexpression of the specific candidate gene.
Mosquitoes overexpressing either Cyp6 gene under the Ubi-A10
driver showed resistance to permethrin (Cyp6m2: 28% mortality,
P < 0.001; Cyp6p3: 43% mortality, P < 0.001) and deltamethrin
(Cyp6m2: 88%, P = 0.04; Cyp6p3: 52%, P = 0.004) compared with
controls (Fig. 1C). A significant difference in mortality was
observed between mosquitoes overexpressing the 2 different Cyp6
genes for deltamethrin assays (P = 0.003), while no significant
difference was observed for permethrin (P = 0.15). However, only
Cyp6p3-overexpressing mosquitoes showed resistance to bendiocarb
(13% mortality, P < 0.001) (Fig. 1C). No resistance to DDT was
observed with either gene in conjunction with the Ubi-A10 driver
(Fig. 1C).
CYP6M2 or CYP6P3 Multitissue Overexpression Increases Susceptibility
to Malathion. Malathion is an OP proinsecticide that is activated
in vivo to the more toxic compound malaoxon through P450-based
oxidative reactions (28). Preliminary analysis showed that a stan-
dard WHO diagnostic dose and 60-min exposure killed all test and
control mosquitoes; however, during exposure, it was clear that Ubi-
A10–directed Cyp6 overexpression induced more rapid knockdown
compared with controls, suggesting malathion activation by these
P450s. We, therefore, examined the relative sensitivity of mosqui-
toes overexpressing Cyp6m2 or Cyp6p3 when exposed to the same
diagnostic dose of this OP for a shorter time (25 min) (Fig. 2).
Under these conditions, mosquitoes overexpressing Cyp6m2 under
the control of the Ubi-A10 driver showed significantly higher
mortality rates compared with controls (95 vs. 15%, P < 0.001) and
Ubi-A10/UAS-p3 mosquitoes (95 vs. 34%, P = 0.002), although the
Fig. 1. Multitissue Cyp6 gene up-regulation affects sensitivity to 2 pyrethroids and a carbamate insecticide. (A) Relative transcription levels of Cyp6m2 (m2+) and Cyp6p3
(p3+) in adult females where expression is driven by the Ubi-A10 driver compared with GAL4/+ controls. Bars represent SD (n = 3). Unpaired t test. **P < 0.01; ***P <
0.001. (B) Expression of CYP6M2 and α-tubulin in adult females from Ubi-A10 × UAS-m2 crosses with respective Ubi-A10/+ and +/UAS-m2 controls. Protein extract from
the equivalent of 1/10 of a whole female mosquito was loaded in each lane. (C) Sensitivity to insecticides of GAL4/UAS (+) females overexpressing Cyp6m2 or Cyp6p3
ubiquitously under the control of the Ubi-A10 driver compared with GAL4/+ controls (−) measured by WHO tube bioassay. Bars represent SD (n = 4 to 6) (SI Appendix,
Table S2). The dotted line marks the WHO 90% mortality threshold for defining resistance. Welch’s t test with P < 0.01 significance cutoff. **P < 0.01; ***P < 0.001.
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latter also showed a trend of increased mortality compared with
Ubi-A10/+ controls (34 vs. 8%, P = 0.05).
Overexpression of GSTE2 in Multiple Tissues Causes Resistance to
Diagnostic Doses of DDT and Fenitrothion. To extend the analysis
to the role of GSTE2 in insecticide resistance in An. gambiae, we
utilized the previously described Ubi-A10 GAL4 line (23) as a
docking line. Integration of the UAS cassette into a single
docking site in this case would provide Ubi-A10GAL4 and UAS-
Gste2 at the same locus (Ubi-A10GAL4:UAS-e2) and should
natively overexpress Gste2 without the need for crossing separate
lines. Alternatively, cassette exchange would generate a regular
UAS-Gste2 responder line. After embryonic injections and
screening, 3 exchange events (2 in orientation A and 1 in orien-
tation B) (SI Appendix, Fig. S1) and 3 integration events were
independently recovered with an overall transformation efficiency
of 9% (6/65 F0), exchange efficiency of 5% (3/65 F0), and in-
tegration efficiency of 5% (3/65 F0) (Table 1).
To obtain comparable data for Gste2 and the Cyp6 genes, we
focused our analysis on the progeny from crosses between UAS-
e2 and Ubi-A10GAL4 mosquitoes. When exposed to diagnostic doses
of DDT, GSTE2-overexpressing mosquitoes showed a significantly
lower mortality (7%, P < 0.001) compared with controls, while
no significant difference in resistance was found when exposed to
diagnostic doses of permethrin, deltamethrin, malathion, or
bendiocarb (Fig. 3). A trend of increased tolerance was observed
in mosquitoes overexpressing Gste2 against malathion (Fig. 3),
and further analysis with the related OP fenitrothion indicated
high resistance in Ubi-A10/UAS-e2 mosquitoes, showing 8% (P <
0.001) mortality (Fig. 3).
Preliminary analysis of Ubi-A10GAL4:UAS-e2 (integration)
mosquitoes indicated the expected increase in GSTE2 protein in
whole-body extracts compared with Ubi-A10 controls (SI Ap-
pendix, Fig. S2A) and a resistance phenotype against DDT in the
F1 generation of transformed male and female mosquitoes (SI
Appendix, Fig. S2B).
Oenocyte or Midgut-Specific Overexpression of CYP6M2 or CYP6P3
Does Not Confer Resistance to Insecticides. To examine the role of
oenocytes and midgut tissues in P450-based metabolism of in-
secticides, we utilized previously published GAL4 driver lines to
regulate tissue-specific expression. The specificity of these GAL4
lines to drive the respective tissue-specific expression has been
established following crosses with UAS-regulated fluorescent gene
reporter lines (22, 24). To examine the relative increase in Cyp6
gene expression, we performed qRT-PCR and western blot anal-
ysis in dissected body parts from progeny of alternative driver and
Cyp6 responder crosses. Using the midgut driver (GAL4-mid),
Cyp6m2 and Cyp6p3 transcripts were 2,730× (P = 0.002) and
659× (P = 0.011) more abundant, respectively, in midguts dis-
sected from GAL4/UAS mosquitoes compared with controls (Fig.
4A). A low level of overexpression was detected in the remaining
carcass of GAL4/UAS mosquitoes compared with that of controls
(Cyp6m2: 77×, P = 0.038; Cyp6p3: 7×, P = 0.08). In GAL4-oeno
crosses, Cyp6m2 and Cyp6p3 were specifically up-regulated in
transgenic dissected abdomens (66×, P = 0.013 for Cyp6m2; 153×,
P < 0.001 for Cyp6p3) where oenocytes are located (Fig. 4B).
Background overexpression was also found in the remaining car-
cass of GAL4/UAS-m2 and -p3 adults compared with controls
Fig. 2. Multitissue Cyp6 gene up-regulation increases sensitivity to the OP
insecticide malathion (25-min exposure). Sensitivity to malathion of females
overexpressing Cyp6m2 (m2+) or Cyp6p3 (p3+) ubiquitously under the
control of the Ubi-A10 driver compared with respective GAL4/+ controls
(m2−, p3−) measure by a modified WHO tube bioassay representing mor-
tality rates after 25 min of exposure and 24-h recovery. Bars represent SD
(n = 4) (SI Appendix, Table S2). Welch’s t test with P < 0.01 significance
cutoff. ***P < 0.001.
Fig. 3. Multitissue overexpression of GSTE2 affects sensitivity to an organochlorine and an OP insecticide. Sensitivity to insecticides of adult female mos-
quitoes overexpressing Gste2 (e2+) ubiquitously under the control of the Ubi-A10 driver compared with Ubi-A10 controls (e2−) measured by WHO tube
bioassay. Bars represent SD (n = 2 to 6) (SI Appendix, Table S2). The dotted line marks the WHO 90% mortality threshold for defining resistance. Welch’s t test
with P < 0.01 significance cutoff. ***P < 0.001.
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(26×, P < 0.001 and 2×, P < 0.001, respectively). In western blot
analysis, CYP6M2 antiserum again only detected the target pro-
tein in GAL4/UAS mosquitoes. CYP6M2 was found exclusively in
dissected midguts (and whole mosquitoes) from the progeny of
GAL4 midcrosses but was not observed in GAL4/UAS carcasses or
extracts from controls (Fig. 4C). Similarly, in GAL4-oeno crosses,
CYP6M2 signal was only detected in whole adult female extracts
and in dissected abdomen integument but not in the remaining
carcass or control extracts (Fig. 4D).
Adult females overexpressing Cyp6m2 in the midgut (Fig. 4E) or
in the oenocytes (Fig. 4F) showed complete susceptibility to per-
methrin, deltamethrin, DDT, and bendiocarb. Similar results were
obtained with Cyp6p3 (Fig. 4 E and F); however, potential resistance
(95% mortality, P = 0.013) was suggested in oenocyte-specific
Cyp6p3-overexpressing mosquitoes when exposed to permethrin
(Fig. 4F). Further analysis was performed to detect subtle differences
in susceptibility by repeating the assays with reduced exposure time
(SI Appendix, Fig. S3). However, no significant decrease (P < 0.01)
Fig. 4. Cyp6 gene up-regulation in the mosquito midgut or oenocytes does not affect sensitivity to insecticides. (A and B) Relative transcription levels of
Cyp6m2 (m2+) and Cyp6p3 (p3+) in dissected midguts (A) and abdomens (B) of GAL4/UAS female mosquitoes compared with the equivalent body parts in
GAL4/+ controls. Carcass is whole body without the relevant dissected part. Bars represent SD (n = 3). Unpaired t test. *P < 0.05; **P < 0.01; ***P < 0.001. (C
and D) Expression of CYP6M2 and α-tubulin in females from the GAL4-mid × UAS-m2 (C) and GAL4-oeno × UAS-m2 (D) crosses. Abd, abdomen cuticle; Car,
protein extract from 1/3 of a single female carcass–whole body without the midgut (C) or the abdomen (D); Mid, 2 dissected midguts; Wh, protein extract
from 1/3 of a single whole female. +, GAL4/UAS-m2; −, GAL4/+. (E and F) Sensitivity to insecticides of GAL4/UAS females overexpressing (+) Cyp6m2 or Cyp6p3
in the midgut (E) or in the oenocytes (F) compared with GAL4/+ controls (−) measured by WHO tube bioassay. Bars represent SD (n = 2 to 3) (SI Appendix,
Table S2). Dotted lines mark the WHO 90% mortality threshold for defining resistance. Welch’s t test with P < 0.01 significance cutoff.
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was found in the mortality rates of mosquitoes overexpressing
Cyp6m2 or Cyp6p3 in the midgut or oenocytes compared with their
respective controls when exposed for 20 min to the same diagnostic
doses of the 4 insecticides (SI Appendix, Fig. S3).
Finally, the 25-min reduced exposure bioassay for malathion
showed no significant difference in the mortality of mosquitoes
overexpressing Cyp6m2 or Cyp6p3 in midgut or oenocytes com-
pared with controls (SI Appendix, Fig. S4).
Discussion
In vivo functional analysis is critical to provide evidence of caus-
ative links between candidate genes and their proposed pheno-
types. Here, we demonstrate the utility of GAL4/UAS-based tools
to characterize gene function directly in An. gambiae by reporting
the use of the system to validate the ability of single candidate
genes to confer WHO-defined resistance to different classes of
insecticides. Overall, the transgenic analysis in An. gambiae is
more in accordance with data generated from recombinant pro-
tein studies of insecticide metabolism rather than those obtained
from D. melanogaster survival assays (Table 2).
In Anopheles, multitissue overexpression of Cyp6m2 and
Cyp6p3 demonstrated that resistance to permethrin and delta-
methrin (types I and II pyrethroids, respectively) can be con-
ferred by the sole overexpression of either Cyp6 gene. Cyp6p3
expression also conferred resistance to bendiocarb (carbamate),
while the overexpression of either Cyp6 gene did not alter DDT
(organochlorine) sensitivity. These phenotypes correlate with the
profile of metabolism or substrate depletion of the respective
insecticides for the 2 recombinant P450 enzymes (Table 2). More
variable results have been observed using D. melanogaster as an
in vivo model, with overexpression of Cyp6m2 surprisingly gen-
erating increased tolerance to bendiocarb compared with
Cyp6p3, despite in vitro analysis not detecting activity against
bendiocarb for Cyp6m2 (15, 19). DDT tolerance was also ob-
served in Cyp6m2-overexpressing D. melanogaster, but data for
Cyp6p3 could not be generated (15) (Table 2). In this study,
DDT resistance was monitored by dose–response assays over a
24-h exposure time, while bendiocarb resistance was not ob-
served when measured through such dose–response assays but
was reported following 24-h exposure to a diagnostic dose. In the
latter case, the controls used to compare Cyp6m2 and Cyp6p3
overexpression showed very different levels of sensitivity to
bendiocarb, which seemed to contribute to the differences in
resistance levels observed, while there were no data for the re-
spective Cyp6p3 controls in the DDT analysis for comparison. It
may thus be differences in the insecticide susceptibility of the
control lines that give rise to the discrepant results observed in D.
melanogaster. Since the D. melanogaster UAS-Cyp6 lines were
also created by PhiC31 transformation, it seems unlikely that the
differences are caused by position effects. However, it should also
be noted that the different methods of insecticide bioassay per-
formed in the D. melanogaster studies may not yield directly com-
parable results with the diagnostic WHO level of resistance in
mosquitoes used in this study and extensively used to assess the
emergence of resistance in endemic countries. Our data in mos-
quitoes unequivocally indicate, however, that the expression of
Table 2. In vitro (metabolism and/or depletion) and in vivo (An. gambiae and D. melanogaster)
functional validation of An. gambiae Cyp6m2, Cyp6p3, and Gste2 genes
Class, insecticide, and gene In vitro An. gambiae (this study) D. melanogaster
Pyrethroids
Permethrin
Cyp6m2 ✓ (11),* (19)† ✓ ✓ (15)
Cyp6p3 ✓ (10),* (19)† ✓ ✓ (15)
Gste2 N/A ✗ ✗ (20)
Deltamethrin
Cyp6m2 ✓ (11),* (19)† ✓ ✓ (15)
Cyp6p3 ✓ (10),* (19)† ✓ ✓ (15)
Gste2 N/A ✗ N/A
Organochlorines
DDT
Cyp6m2 ✗ (19),† ✓ (12)*,‡ ✗ ✓ (15)
Cyp6p3 ✗ (19)† ✗ N/A
Gste2 ✓ (9, 13)* ✓ ✓ (13, 20)
Carbamates
Bendiocarb
Cyp6m2 ✗ (15, 19)† ✗ ✓ (15)
Cyp6p3 ✓ (15, 19)† ✓ ✓ (15)
Gste2 N/A ✗ N/A
Organophosphates
Malathion
Cyp6m2 ✓ (28),* (19)† ✓ N/A
Cyp6p3 ✓ (19)† ✓ N/A
Gste2 N/A ✗ N/A
Fenitrothion
Cyp6m2 ✓ (19)† N/A N/A
Cyp6p3 ✓ (19)† N/A N/A
Gste2 N/A ✓ N/A
Presence (✓) or absence (✗) of in vitro activity or in vivo WHO-defined insecticide resistance (An. gambiae) or
increased insecticide tolerance (D. melanogaster). N/A, no information available.
*Data in reference indicated that metabolism of substrate had been observed through the production of
metabolites.
†Data in reference indicated that substrate had been depleted with no direct evidence of metabolite production.
‡In the presence of added cholate.
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single Cyp6 genes can confer resistance to different pyrethroids and
that Cyp6p3 overexpression confers cross-resistance to prominent
representatives of at least 2 classes of public health insecticides.
In contrast to our Cyp6 studies, increased An. gambiae Gste2
(AgGste2) expression generates clear DDT resistance, while re-
sistance to bendiocarb and pyrethroids was not observed. These
phenotypes again validate predictions from the DDT activity ob-
served in vitro for recombinant AgGSTE2 (9, 13) as well as the
increased DDT tolerance (13) and lack of pyrethroid tolerance (20)
observed when overexpressed in D. melanogaster. The correspond-
ing in vitro data for AgGSTE2 activity against bendiocarb and py-
rethroids have not been reported, and here, bendiocarb resistance
has been examined in vivo following Gste2 overexpression.
Although DDT tolerance was also observed in D. melanogaster
overexpressing the orthologous AfGste2 (16, 18), conflicting
results were reported about activity toward pyrethroids. For ex-
ample, recombinant AfGSTE2 depleted permethrin but not
deltamethrin in vitro, yet D. melanogaster acquired increased
tolerance to both insecticides when AfGste2 was overexpressed
(16, 18). RNAi analysis in deltamethrin-resistant Aedes aegypti of
AaGste2 has also indicated a role in pyrethroid resistance (29). It
is possible that the variation observed in resistance profiling is due
to intrinsic differences in the activity of GSTE2s derived from the
different mosquito species. In this context, it has been speculated
that the predominant pyrethroid detoxification role of GSTs in
some insects is sequestration or protection against oxidative stress
rather than direct metabolism (30). Our results show that even
high levels of AgGste2 overexpression do not confer WHO di-
agnostic levels of resistance to this class of insecticides in isolation.
It is feasible that the level of glutathione cofactor is limiting in the
mosquito; however, this seems unlikely, since the recombinant
enzyme does not show pyrethroid metabolizing activity, even in
the presence of excess glutathione (20). It is also possible that
AgGste2may need to work in concert with other genes that are not
up-regulated in the sensitive genetic background of the An. gambiae
transgenic lines to produce a pyrethroid resistance phenotype. Future
work will test this hypothesis by coexpression of other UAS-regulated
detoxification genes using the Ubi-A10GAL4:UAS-e2 (integration)
line. Although beyond the scope of this work, this mosquito line
expresses GAL4 and GSTE2 and can be crossed with other UAS
lines to provide coexpression with other detoxification enzymes to
examine additive or synergistic interactions.
Although GSTs have been associated with OP metabolism
through biochemical studies (7), we report evidence that the
expression of a single gene can provide OP resistance in mos-
quitoes. The high resistance shown toward fenitrothion by Gste2-
overexpressing An. gambiae is intriguing. It is currently unclear if
GSTE2 detoxifies fenitrothion by sequestration, by free radical
protection, or directly through conjugation/modification. Evi-
dence from early studies (31) suggests that Anopheles GST ac-
tivity is associated with the conversion of fenitrothion to the
nontoxic metabolite desmethyl fenitrooxon through an oxidized
intermediate. Similar analysis in the Gste2-overexpressing lines
would clarify which of these mechanisms is involved. Further
investigation is also needed on the OP malathion, for which we
report suspected resistance when Gste2 is overexpressed.
We have also demonstrated that Cyp6 overexpression increases
susceptibility to malathion as well as conferring permethrin re-
sistance, which may have direct implications on insecticide man-
agement, especially if replicated with other OPs that may be used
for Anopheles control (32). Such sensitivity profiles are readily
explained by the bioactivation of malathion to its more toxic
metabolite malaoxon (33) by a P450-mediated mechanism (28).
Direct evidence of activation has been shown by mass spectrom-
etry analysis of in vitro CYP6M2 activity against malathion, which
identified a major metabolite of 315 Da, corresponding to
malaoxon (28). Here, we provide direct in vivo evidence that
CYP6 enzymes can confer negative cross-resistance. Furthermore,
there seems to be substrate specificity in the alternative P450-
mediated reactions, since we observed higher mortality when
assayed against Cyp6m2 overexpression compared with Cyp6p3.
This may suggest that Cyp6m2 favors the higher steady-state
production of the toxic intermediate compared with Cyp6p3.
Malathion activation by Cyp6m2 is also supported by recent ev-
idence provided by Ingham et al. (34), who found that knockdown
of the transcription factor Maf-S results in increased survival fol-
lowing malathion exposure. One of the P450s down-regulated by
Maf-S knockdown was Cyp6m2, whereas Cyp6p3 transcription was
not modified. Taken together, the results provide experimental
evidence to support the use of OPs and potentially, other proin-
secticides activated by CYP6 enzymes for Anopheles control in areas
where pyrethroid resistance is also conferred by detoxification by
the same enzyme(s). One such strategy involves combining the use
of pyrethroid-based bed nets with OP-based residual wall spraying
or impregnated hangings (32). This takes advantage of the additive
effect of the 2 classes of insecticides while sensitizing Cyp6-based
pyrethroid-resistant mosquitoes to malathion (35). In conjunction
with recombinant enzyme assays, the modified mosquitoes de-
scribed may thus become valuable tools to assess the susceptibility
of public health proinsecticides (for example, chlorfenapyr [36]) to
activation and detoxification by xenobiotic metabolizing P450 genes
in Anopheles.
When validating resistance phenotypes conferred by transgenic
overexpression, the spatial pattern of overexpression can give clues
to the identity of key tissues of detoxification. The expression
driven by Ubi-A10 is spread over multiple tissues, which makes it
impossible to pinpoint which tissues are particularly important for
generating the resistance phenotype. Here, we directly investigated
the involvement of the midgut and oenocytes in conferring P450-
mediated resistance. Critically, we did not observe clear resistance
to any insecticide class when either Cyp6m2 or Cyp6p3 was spe-
cifically expressed in either of these tissues, despite achieving highly
enriched expression and the knowledge that oenocytes and the
midgut express abundant P450 coenzyme CPR (26). Furthermore,
since our previous expression profiling of the Ubi-A10 driver in-
dicated lack of expression in Malpighian tubules (23), yet resistance
to multiple insecticides was observed with this driver, it would seem
that the insecticides tested are not predominately metabolized in
the Malpighian tubules either, and other unidentified tissues may
be critical, alone or in combination, for detoxification. As described
earlier, some evidence of tissue specificity of P450s associated with
insecticide resistance has been derived from transcriptomic analysis
of crude dissections of tissues and body segments from pyrethroid-
resistant and -sensitive strains (27). This study indicated that
Cyp6p3 is more highly expressed in the midgut of the resistant
strain, whereas Cyp6m2 has a broader up-regulation in midgut,
Malpighian tubules, and the abdomen (integument, fat body, and
ovaries). The relevance of elevated Cyp6p3 levels in the midgut of
the examined resistant strain is difficult to reconcile with the lack
of a resistance phenotype when the same gene is overexpressed in
this tissue with the GAL4/UAS system.
Previous D. melanogaster studies have shown that overexpression
using drivers active in multiple tissues, such as actin5C-GAL4 (14–
18) or tubulin-GAL4 (20), is generally needed to modify resistance.
Nevertheless, there are few examples in which tissue-specific drivers
have been used to validate Cyp6 gene-based resistance in D. mela-
nogaster. Yang et al. (37) demonstrated the central role of Mal-
pighian tubules for DmCyp6g1-mediated DDT resistance, while Zhu
et al. (38) demonstrated the importance of neuronal expression to
provide deltamethrin resistance in D. melanogaster expressing
Tribolium castaneum Cyp6bq9. Even in this latter analysis, however,
the neuronal driver showed leaky expression in other tissues, lead-
ing to the possibility that the observed phenotype results from ex-
pression in multiple tissues. Further work in D. melanogaster with
alternative tissue-specific drivers could be exploited to provide in-
sight into the involvement of particular tissues in Cyp6-mediated
Adolfi et al. PNAS Latest Articles | 7 of 9
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resistance. When similar tools become available in mosquitoes, a
more definitive answer to which specific tissues are involved in the
detoxification of insecticides in An. gambiae can be provided.
Conclusions
This work reports on functional analysis of mosquito insecticide re-
sistance genes conducted in transgenic An. gambiae. The mosquitoes
generated are resistant, in a solely metabolism-based manner, to at
least 1 representative insecticide from the major classes used in
public health and are, therefore, useful in prescreens of new and
repurposed active compounds, including insecticides, proinsecticides,
synergists, and sterilizing agents. The lines can also be used in
combination with strains carrying genome-edited target sites (e.g.,
Kdr and Ace-1R) to examine the additive or synergistic effects of
multiple resistance mechanisms. Similarly, it is possible to use the
integration line carrying both Ubi-GAL4 and UAS-Gste2 to cross
with other UAS detoxification genes to analyze metabolic interac-
tions: for example, combining phases I and II metabolism. In addi-
tion, the Ubi-A10 driver is active in larval stages (23) and can thus be
used to examine gene function in immature stages.
Importantly, for future work, there is growing evidence on the
involvement in resistance of genes that are very difficult to test
either in vitro, due to the lack of appropriate assays, or in D.
melanogaster, since interacting partner proteins may be different
or absent. These include genes coding for cuticle components
(39), transcription factors (34), and other binding proteins (e.g.,
hexamerins and α-crystallins [21]), for which current transgenic
tools, including GAL4/UAS, make An. gambiae the most rele-
vant option for functional genetic analysis.
Materials and Methods
Plasmid Construction. Responder plasmids were designed for the expression of
the An. gambiae genes Cyp6m2 (AGAP008212), Cyp6p3 (AGAP002865), or Gste2
(AGAP009194) under the regulation of the UAS and carried a YFP marker gene
regulated by the 3xP3 promoter. The coding sequences of Cyp6m2 (1,500 bp),
derived from the susceptible strain Kisumu, were amplified from PB13:CYP6M2
(11) using primers M2fw and M2rv (SI Appendix, Table S1). The coding sequence
of Cyp6p3 was obtained by amplifying a 193-bp fragment from Kisumu com-
plementary DNA using primers P3fw1 and P3rv1 (SI Appendix, Table S1) and a
1,362-bp fragment from pCW:17α-Cyp6p3 (10) using primers P3fw2 and P3rv2 (SI
Appendix, Table S1). P3fw1 and P3rv2 were then used to join the 2 fragments
and obtain the 1,530-bp full-length Cyp6p3 coding sequence. The 666-bp Gste2-
114T coding sequence derived from the DDT-resistant strain ZAN/U was ampli-
fied from the K1B plasmid (13) using primers Gste2k1bfor and Gste2k1brev (SI
Appendix, Table S1). All coding sequences were cloned into the YFP-marked
responder plasmid pSL*attB:YFP:Gyp:UAS14i:Gyp:attB (24) downstream of the
UAS using EcoRV/XhoI (Cyp6) or EcoRI/NcoI (Gste2).
Creation of UAS Responder Lines by PhiC31-Mediated Cassette Exchange. For
creating responder lines carrying Cyp6 genes, embryos of the docking line
A11 (24), which carries 2 inverted attP sites and is marked with 3xP3-driven
CFP, were microinjected with 350 ng/μL of the responder plasmid and
150 ng/μL of the integrase helper plasmid pKC40 encoding the phiC31 integrase
(40) as described in Pondeville et al. (41). The same protocol was followed
to create the Gste2 responder line using embryos of the docking line Ubi-A10
(23), which carries 2 inverted attP sites and is marked with 3xP3-driven CFP.
Emerging F0 was pooled into sex-specific founder cages and outcrossed with
wild-type G3s. F1 progenies were screened for the expression of YFP (cas-
sette exchange) and CFP/YFP (cassette integration) in the eyes and nerve
cord. Orientation check to assess the direction of cassette exchange was
performed on F1 YFP-positive individuals or on the F2 progeny deriving from
single YFP-positive individuals. This was carried out by PCR using alternative
combinations of 4 primers designed to give a product only in 1 of the ori-
entations: Two pairs were diagnostic for orientation A, and two pairs were
diagnostic for orientation B. Mosquito DNA with an insertion in orientation
A gives products only with PiggyBacR-R2 + Red-seq4R (PCR1) and gene-
specific primers M2intFW or P3intFW or Gste2_v1 + ITRL1R (PCR2). Mosquito
DNA with an insertion in orientation B gives products only with PiggyBacR-
R2 + gene specific primers M2intFW or P3intFW or Gste2_v2 (PCR3) and Red-
seq4R + ITRL1R (PCR4). All definitive responder lines were created from
individuals showing orientation of insertion A, which was chosen for consis-
tency with previous RMCE lines created in this laboratory. Transformation
efficiencies were calculated as the number of independent transgenic events
(exchanges or integrations) over the number of surviving F0 adults.
Driver Lines and GAL4 × UAS Crosses. Crosses for ubiquitous expression were
established between the CFP-marked driver Ubi-A10 (23) and individuals of
the responder lines marked with YFP. To obtain tissue-localized expression,
dsRed-marked drivers specific for expression in the midgut (GAL4-mid) (22)
or in the oenocytes (GAL4-oeno) (24) were used. Responder lines were kept
as a mix of homozygous and heterozygous individuals so as to obtain
GAL4/+ progeny to be used as transgenic blank controls.
Cyp6 Gene Expression Analysis. To quantify Cyp6 gene expression in GAL4/
UAS and GAL4/+ individuals, total RNA was harvested from pools of 2- to
5-d-old whole adults and their relevant dissected body part (midgut or ab-
domen cuticle). The adult tissues remaining after dissection constituted the
carcass. Three biological replicates consisting of 5 mosquitoes (or body parts)
each were collected from each mosquito population. RNA extraction was
performed using the TRI Reagent protocol (Sigma). To remove genomic
DNA contamination, samples were treated with the Turbo DNA-Free kit
(Ambion). RNA was then reverse transcribed using the SuperScript III First-
Strand Synthesis System (Life Technologies) following the oligo(dT) reaction
protocol. qRT-PCR reactions were set up using 1× Brilliant III Ultra-Fast SYBR
Green qPCR Master Mix (Agilent Technologies) and primers qM2fw and qM2rv
for quantification of Cyp6m2 and qP3fw and qP3sub for Cyp6p3 (15) (SI Ap-
pendix, Table S1). The qP3sub primer bears a nucleotide substitution (A11G) to
conform its sequence to that of the G3 strain template. Two housekeeping
genes, the ribosomal protein S7 (AGAP010592) and the ribosomal protein L40/
Ubiquitin (AGAP007927), were also quantified using primers qS7fw, qS7rv,
qUBfw, and qUBrv (42) (SI Appendix, Table S1). Cyp6 transcription data
obtained by qRT-PCR were analyzed using the ΔΔ cycle threshold (Ct) method
as described in SI Appendix, Supplementary Method. Gene expression analysis
was not performed to assess up-regulation of the Gste2 transcript.
CYP6 and GSTE2 Protein Expression Analysis. To detect protein expression in
GAL4/UAS and GAL4/+ individuals, total protein extracts were obtained from
whole 2- to 5-d-old female adults and their dissected body parts. Whole mos-
quitoes and dissected body parts were directly homogenized in 1× Laemmli
buffer (BioRad) containing 5% 2-mercaptoethanol and 1× protease inhibitors
(cOmplete EDTA-free Protease Inhibitor Mixture; Sigma), incubated at 95 °C for
10 min, and then, centrifuged at 13,000 rpm for 5min. Volumes of protein extract
were separated by sodium dodecylsulphate/polyacrylamide gel electrophoresis to
give the number of whole mosquito or body part equivalents as indicated.
Protein extracts equivalent to 1/3 of a mosquito or its body part were
analyzed to detect CYP6 expression driven by tissue-specific drivers with the
exception of midgut samples, for which 2 whole midguts were analyzed.
The higher amount of midgut sample was required to visualize signal of the
α-tubulin loading control. The equivalent of 1/10 of a single female mos-
quito was used to assess expression driven by ubiquitous drivers. CYP6s were
probed using primary affinity-purified polyclonal peptide antibodies pro-
duced in rabbit against CYP6M2 or CYP6P3 (gifts from M. Paine Liverpool
School of Tropical Medicine (LSTM), Liverpool, UK), while GSTE2 was probed
with anti–GSTE2-28 rabbit primary antibodies (9). Secondary antibodies
were anti-rabbit horseradish peroxidase (HRP)-tagged immunoglobulins G
(IgG). (Bethyl Laboratories). Relative protein loading and blotting efficacy
was verified by reprobing stripped membranes (Restore ThermoFisher) using
primary mouse anti–α-tubulin antibodies (Sigma) and secondary goat anti-
mouse HRP IgG antibodies (Abcam). Signal detection was carried out using
SuperSignal West Dura Extended Duration Substrate (Life Technologies).
Assessment of Susceptibility to Insecticides. Susceptibility to insecticides was
assessed in mosquitoes overexpressing Cyp6 genes using the WHO tube bio-
assay (25). Pools of 20 to 25 GAL4/UAS and GAL4/+ adult female mosquitoes
were exposed 2 to 5 d postemergence to standard discriminating doses of
insecticides—0.75% permethrin, 0.05% deltamethrin, 0.1% bendiocarb, and
4% DDT—for 60 min, and mortality rates were assessed after a 24-h recovery
period. For mosquitoes expressing Cyp6 genes in the midgut or oenocytes, a
modified version of the standard WHO test was also performed, reducing the
exposure time to 20 min (26). For assessing susceptibility to 5% malathion in
mosquitoes overexpressing Cyp6 genes, the exposure time was decreased to
25 min. Mosquitoes overexpressing Gste2 were additionally tested for 1%
fenitrothion using the recommended 2-h exposure time; 1 to 4 biological
replicates were performed for each insecticide tested. A total of 2 to 8 tech-
nical replicate tubes were tested for each population. Welch’s t test was per-
formed to determine statistical differences between mortality rates in GAL4/
UAS and GAL4/+. Details on replicate numbers of insecticide bioassay
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experiments and statistical analysis are reported in SI Appendix, Table S2. All
statistics were calculated using GraphPad Prism version 8.2.1 (GraphPad
Software; https://www.graphpad.com/).
Data Availability.All extant transgenic lines, primary antibodies, and plasmids
described will be provided by G.J.L. on request. The raw bioassay data can be
accessed at Figshare (43).
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